A new type of human TWEAK receptor antibody (TweakR, Fn14, TNFRSF12A, and CD266) PDL192 was found to directly inhibit tumor cell growth and antibody-dependent cytotoxicity in a variety of mouse xenograft models, showing strong antitumor effects active [36]. The gene discussed is TNFRSF12A; the disease is neoplasm.